Personalising ventilation for better patient care

Our lung monitoring technology InspiWave^TM helps physicians personalizing mechanical ventilation to improve patient safety.

Mission

To make personalized mechanical ventilation a new standard of care.

The problem: The safety of Mechanical Ventilation Management

Currently bedside physicians rely on one-size fit-all protocols to decide ventilator settings.

This current approach is unsafe. Too much gas delivered to a patient’s lung causes overinflation that can lead to lung injury. Similarly, inappropriate pressure applied to the lung causes harmful stress that also leads to lung injury. The fact that the ventilator can cause damage to the lung is commonly known as Ventilator-induced Lung Injury.

Our Solution

By providing important lung information in a simple way to set up and use, InspiWave^TM lung monitor guides physicians to choose appropriate mechanical ventilator settings according to the needs of that individual by the bedside, in real time, while does not interfere with their works. In other words, the InspiWave^TM technology enables personal mechanical ventilation to improve patient safety.

The problem in numbers

Currently 15m people need mechanical ventilation a year. Being on ventilator:

Healthy lung has 25% risk of developing lung injury[1].
Injured lung has 80% risk of worsening injury due to wrong setting, ~8% of which results in death[2].

Ventilator-induced lung injury is most damaging in patients with acute respiratory distress syndrome (ARDS) – the worse form of acute lung injury. A highlight of this condition can found on https://ardsglobal.org/.

Refs:

1: Gajic O, Dara SI, Mendez JL, Adesanya AO, Festic E, Caples SM, Rana R, St Sauver JL, Kymp JF, Afessa B, Hubmayr RD. Ventilator-associated lung injury in patients without acute lung injury at the onset of mechanical ventilation. Crit Care Med. 2004;32:1817–1824. doi: 10.1097/01.CCM.0000133019.52531.30.

2: Marti J, Hall P, Hamilton P, Lamb S, McCabe C, Lall R, Darbyshire J, Young D, Hulme C. One-year resource utilisation, costs and quality of life in patients with acute respiratory distress syndrome (ARDS): secondary analysis of a randomised controlled trial. J Intensive Care. 2016 Aug 11;4:56. doi: 10.1186/s40560-016-0178-8. PMID: 27525106; PMCID: PMC4982209.